Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938665 · ClinicalTrials.gov registry record
Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
A clinical trial, sponsored by Neuronetrix.
- Completed
- Registry status
- 204
- Enrollment target
NCT00938665: Completed study, sponsored by Neuronetrix.
NCT00938665 is a clinical trial that has completed, run by Neuronetrix. The registered enrollment target is 204 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00938665 has completed, sponsored by Neuronetrix.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
Study Summary
The proposed study is designed to evaluate the performance of the COGNISION™ System as a tool to assist physicians in diagnosing Alzheimer's Disease (AD) in real-world clinical settings. The design of this study is guided by two overriding factors: 1) to optimize the performance of the event related potentials (ERP) classifiers, the subjects making up the training sets must be well characterized as to their clinical diagnosis, and 2) all ERP tests must be performed and reproduced in real-world clinical settings.
Interventions
- DEVICE COGNISION™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-02 |
What the finished NCT00938665 record still lists
NCT00938665 is an observational study that tracks outcomes without assigning an intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which COGNISION™ System is the first listed.
NCT00938665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00938665 about?
NCT00938665 is a clinical study titled "Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.". The proposed study is designed to evaluate the performance of the COGNISION™ System as a tool to assist physicians in diagnosing Alzheimer's Disease (AD) in real-world clinical settings. The design of this study is guided by two overriding factors: 1) to optimize the performance of the event related...
What is the current status of trial NCT00938665?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2010-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00938665?
The interventions under investigation include: COGNISION™ System (DEVICE).
Who is sponsoring clinical trial NCT00938665?
This trial is sponsored by Neuronetrix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia